About

Contagious

The main objective of this trial that is run by UZ Leuven/KU Leuven, is to clinically and immunologically characterize patients hospitalized in UZ Leuven due to a SARS-CoV-2 infection. Samples from patients in the three disease stages (mild, moderate, severe) will be collected (blood, nasal/rectal swab, bronchoalveolar lavage fluid and post-mortem tissue samples) to identify host factors that mediate (hyper)susceptibility to SARS-CoV-2. These data will be used to help guide physicians in treating COVID-19 patients.  

As such, the project consortium concentrates on epidemic control: novel molecular insights in COVID-19 disease progression as a guide to treat patients in the different stages of the disease.